Skip to main content

Table 4 Baseline biological characteristics of children who died

From: Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa

Pt#

Sex

Age (Yrs)

WHO Stage

WAZ

CD4%

ARV Regimen

ARV time to death (weeks)

ALB(g/L)

ALT(IU/L)

HGB(g/dl)

Suspected cause of death

1

M

0.3

4

-

37.6%

d4T/3TC/Kal

09

25.0

14.0

9.9

Chronic gastroenteritis

2

F

7.5

4

-9.52

7.9%

AZT/3TC/EFV

20

18.0

33.0

10.7

TB Miliary

3

F

9.8

4

-4.34

0.8%

d4T/3TC/EFV

14

30.0

12.0

7.9

TB Adenopathy

4

M

3.0

4

-4.81

-

AZT/3TC/Kal

10

-

-

9.1

TB Lymph

5

F

7.1

3

-5.94

8.0%

d4T/3TC/EFV

06

32.0

24.0

11.7

Chronic gastroenteritis

6

F

0.8

3

-7.50

6.0%

d4T/3TC/Kal

01

26.0

116.0

7.0

Chronic gastroenteritis

7

F

1.5

4

-5.42

27.0%

d4T/3TC/RTV

05

28.0

53.0

10.2

TB Abdomen

8

F

13.4

3

-9.51

2.1%

d4T/3TC/EFV

02

-

-

10.1

Chronic gastroenteritis

9

M

0.5

4

-5.24

4.0%

d4T/3TC/Kal

05

25.0

45.0

11.7

Chronic gastroenteritis

10

M

6.3

3

-

1.1%

AZT/3TC/EFV

05

39.0

16.0

9.3

Chronic gastroenteritis

11

M

12.2

3

-6.95

1.0%

d4T/3TC/EFV

06

-

-

5.6

Suspected PCP

12

F

1.1

3

-0.87

1.0%

d4T/3TC/Kal

01

19.0

8.0

4.1

Sepsis syndrome

13

M

5.2

3

-6.71

0.5%

d4T/3TC/EFV

08

28.0

8.3

7.0

Respiratory tract infection

  1. d4T, stavudine; 3TC, lamivdine; AZT, zidovudine; ddI, didanosine; EFV, efavirenz; RTV, Ritonavir; Kal, Kaletraâ„¢